Chemically modified carbon paste electrode for the potentiometric flow injection analysis of piribedil in pharmaceutical preparation and urineIBRAHIM, Hosny.Journal of pharmaceutical and biomedical analysis. 2005, Vol 38, Num 4, pp 624-632, issn 0731-7085, 9 p.Article

Early piribedil monotherapy of Parkinson's disease : A planned seven-month report of the REGAIN studyRASCOL, Olivier; DUBOIS, Bruno; CALDAS, Alexandre Castro et al.Movement disorders. 2006, Vol 21, Num 12, pp 2110-2115, issn 0885-3185, 6 p.Article

Electroanalytical characteristics of piribedil and its differential pulse and square wave voltammetric determination in pharmaceuticals and human serumUSLU, Bengi; ÖZKAN, Sibel A.Journal of pharmaceutical and biomedical analysis. 2003, Vol 31, Num 3, pp 481-489, issn 0731-7085, 9 p.Article

Piribédil: attaques de sommeil, chez des patients non parkinsoniens aussiLa Revue Prescrire. 2013, Vol 33, Num 355, issn 0247-7750, p. 351Article

STUDIO TERMOGRAFICO DELLE VARIAZIONI DI APPORTO SANGUIGNO NEL DISTRETTO CAROTIDO-OFTALMICO IN SOGGETTI TRATTATI CON PIRIBEDIL = ETUDE THERMOGRAPHIQUE DES VARIATIONS DE L'APPORT SANGUIN DANS LE TERRITOIRE CAROTIDO-OPHTALMIQUE CHEZ LES SUJETS TRAITES PAR LE PIRIBEDILGHISOLFI A; TAFI A.1976; MINERVA MED.; ITAL.; DA. 1976; VOL. 67; NO 26; PP. 1681-1688; BIBL. 14 REF.Article

ACTION DE DIVERS REACTIFS PHARMACOLOGIQUES SUR LES MOUVEMENTS STEREOTYPES PRODUITS CHEZ LE RAT PAR L'INJECTION DE 1-(2PYRIMIDYL)-4 PIPERONYL PIPERAZINE (PIRIBEDIL)POIGNANT JC; LAUBIE M; TSOUCARIS KUPFER D et al.1972; C. R. ACAD. SCI., D; FR.; DA. 1972; VOL. 275; NO 5; PP. 715-717; BIBL. 7REF.Serial Issue

INTERET DU PIRIBEDIL DANS LE TRAITEMENT DES VASCULOPATHIES RETINIENNES DEGENERATIVESPERDRIEL G; CHEVALERAUD JP; DECROIX G et al.1974; BULL. SOC. OPHTALMOL. FR.; FR.; DA. 1974; VOL. 74; NO 4; PP. 445-448Article

ET495 AND BRAIN CATECHOLAMINE MECHANISMS: EVIDENCE FOR STIMULATION OF DOPAMINE RECEPTORS = ET495 ET MECANISMES DES CATECHOLAMINES CEREBRALES: MISE EN EVIDENCE DE LA STIMULATION DES RECEPTEURS DOPAMINERGIQUESCORRODI H; FARNEBO LO; FUXE K et al.1972; EUROP. J. PHARMACOL.; NETHERL.; DA. 1972; VOL. 20; NO 2; PP. 195-204; BIBL. 1P.1/2Serial Issue

Orodispersible Sublingual Piribedil to Abort OFF Episodes: A Single Dose Placebo-Controlled, Randomized, Double-Blind, Cross-Over StudyRASCOL, Olivier; AZULAY, Jean-Philippe; GROUIN, Jean-Marie et al.Movement disorders. 2010, Vol 25, Num 3, pp 368-376, issn 0885-3185, 9 p.Article

Piribedil-selective electrodes based on Bi(III)-iodide and Hg(II)-iodide complexesABDEL-GAWAD, Fatama M; ISSA, Yousry M; HASSOUNA, Mohamed E. M et al.Mikrochimica acta (1966. Print). 2003, Vol 141, Num 1-2, pp 7-13, issn 0026-3672, 7 p.Article

Récepteurs α₂-adrénergiques et maladie de Parkinson = α2-adrenergic receptors and Parkinson's diseaseBONNET, Anne-Marie.La Presse médicale (1983). 2002, Vol 31, Num 25, pp 1193-1195, issn 0755-4982Article

UTILIZZAZIONE TERAPEUTICA DEL PIRIBEDIL NELLE AFFEZIONI VASCOLARI DELL'OCCHIO = UTILISATION THERAPEUTIQUE DU PIRIBEDIL DANS LES AFFECTIONS VASCULAIRES DE L'OEILSOLE P; RIGAL D; BACIN F et al.1976; MINERVA MED.; ITAL.; DA. 1976; VOL. 67; NO 26; PP. 1689-1695Article

Piribedil and bromocriptine in Parkinson's disease: a single-blind crossover studyTAN, E. K; RATNAGOPAL, P; HAN, S. Y et al.Acta neurologica scandinavica. 2003, Vol 107, Num 3, pp 202-206, issn 0001-6314, 5 p.Article

Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedilTHOBOIS, Stéphane; LHOMMEE, Eugénie; PELISSIER, Pierre et al.Brain. 2013, Vol 136, pp 1568-1577, issn 0006-8950, 10 p., 5Article

Quantitative determination of some pharmaceutical piperazine derivatives through complexation with iron(III) chlorideABOU-ATTIA, F. M; ISSA, Y. M; ABDEL-GAWAD, F. M et al.Il Farmaco (Pavia). 2003, Vol 58, Num 8, pp 573-579, issn 0014-827X, 7 p.Article

Activité du piribédil dans la maladie de Parkinson : Etude multicentrique = Activity of piridebil in Parkinson's disease : a multicenter studyZIEGLER, M; RONDOT, P.La Presse médicale (1983). 1999, Vol 28, Num 26, pp 1414-1418, issn 0755-4982Article

COMPARATIVE EFFECTS OF APOMORPHINE, PIRIBEDIL AND OTHER NEUROTROPIC AGENTS ON CENTRAL ANALGESIC-INDUCED CATATONIA IN THE RAT = EFFETS COMPARES DE L'APOMORPHINE, DU PIRIBEDIL ET DES AUTRES AGENTS NEUROTROPES SUR LA CATATONIE CENTRALE INDUITE PAR LES ANALGESIQUES CHEZ LE RATPOIGNANT JC; GRESSIER H; MALECOT E et al.1974; EUROP. J. PHARMACOL.; NETHERL.; DA. 1974; VOL. 29; NO 1; PP. 195-199; BIBL. 10REF.Article

DETERMINATION OF PIRIBEDIL IN BIOLOGICAL MATERIALS BY GAS-LIQUID CHROMATOGRAPHY-MASS FRAGMENTOGRAPHYFANELLI R; FRIGERIO A.1974; J. CHROMATOGR.; NETHERL.; DA. 1974; VOL. 93; NO 2; PP. 441-446; BIBL. 10REF.Article

DOPAMINE AGONIST AND ANTAGONIST ACTIVITIES OF PIRIBEDIL (ET495) AND ITS METABOLITES = ACTIVITES AGONISTES ET ANTAGONISTES DE LA DOPAMINE DU PIRIBEDIL (ET495) ET DE SES METABOLITESCOSTALL B; NAYLOR RJ.1974; ARCH. (NAUNYN-SCHMIEDEBERG'S) PHARMACOL.; GERM.; DA. 1974; VOL. 285; NO 1; PP. 71-81; BIBL. 1P.1/2Article

TRATTAMENTO MEDICO A LUNGO TERMINE DEI POSTUMI DELLE CEREBROVASCULOPATHIE ACUTE. CONFRONTO PAPAVERINA/PIRIBEDIL = TRAITEMENT MEDICAL A LONG TERME DES SEQUELLES DE CEREBROVASCULOPATHIES AIGUES. COMPARAISON PAPAVERINE-PIRIBEDILPICCINELLI A; NERI G; AGNOLI A et al.1974; MINERVA MED.; ITAL.; DA. 1974; VOL. 65; NO 80; PP. 4199-4213; ABS. ANGL.; BIBL. 19 REF.Article

CLONIDINE AND THE ANTI-PARKINSONIAN RESPONSE TO L-DOPA OR PIRIBEDIL = LA CLONIDINE ET LA REPONSE ANTIPARKINSONIENNE A LA L-DOPA ET AU PIRIBEDILSHOULSON I; CHASE TN.1976; NEUROPHARMACOLOGY; G.B.; DA. 1976; VOL. 15; NO 1; PP. 25-27; BIBL. 21 REF.Article

PIRIBEDIL (ET 495) IN THE TREATMENT OF PARKINSON'S DISEASE COMBINED WITH AMANTADINE OR LEVOPODA.CALLAGHAN N; FITZPATRICK E; O'MAHONY JB et al.1975; ACTA NEUROL. SCAND.; DANEM.; DA. 1975; VOL. 52; NO 3; PP. 179-186; BIBL. 14 REF.Article

LANGZEITBEHANDLUNG DES NEUROVASKULAEREN PSYCHOSYNDROMS MIT TRIVASTAL. = TRAITEMENT A LONG TERME DU SYNDROME PSYCHIQUE NEUROVASCULAIRE PAR LE TRIVASTALSCHOLING WE; CLAUSEN HD.1975; MED. KLIN.; DTSCH.; DA. 1975; VOL. 70; NO 38; PP. 1522-1527; ABS. ANGL.; BIBL. 19 REF.Article

CLINICAL STUDIES WITH DOPAMINE-RECEPTOR STIMULANTS.ANGRIST B; THOMPSON H; SHOPSIN B et al.1975; PSYCHOPHARMACOLOGIA; ALLEM.; DA. 1975; VOL. 44; NO 3; PP. 273-280; BIBL. 1 P. 1/2Article

SUPPRESSION OF DRINKING AND INDUCTION OF SEDATION BY A DOPAMINE AGONIST IS BLOCKED BY SMALL DOSES OF SPIPERONEDOURISH CT; COOPER SJ.1982; NEUROPHARMACOLOGY; ISSN 0028-3908; GBR; DA. 1982; VOL. 21; NO 1; PP. 69-72; BIBL. 19 REF.Article